ArticleHeliyon2024

A label free chemoproteomic-based platform to disclose cannabidiol molecular mechanism of action on chronic myelogenous leukemia cancer cells.

Sara Ceccacci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.